clinical study on sooli kanam (Bronchial asthma) with evaluation of siddha trial drug - Kannaiku atthi nei in children

PhaseII non randomized clinical study on sooli kanam (Bronchial asthma) with evaluation of siddha trial drug - Kannaiku atthi nei

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028491

Enrollment

Registered

2020-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: KANNAIKU ATTHI NEI: 2 to 5 ml is given twice a day for 21 days Intervention2: KANNAIKU ATTHI NEI: 2 TO 5 ML given twice a day for 21 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: age 3 to 12 years cough without expulsion wheezing dyspnea rhinitis

Exclusion criteria

Exclusion criteria: primary complex hypersensitivity pneumonitis lung abscess cystic fibrosis bronchiolitis

Design outcomes

Primary

Measure	Time frame
clinical assesment of bronchial asthma is carried out on the basis of modified asthma scale, and comparing the clinical symptoms before and after treatmentTimepoint: 21 days	—

Secondary

Measure	Time frame
it is assessed by comparing the safety parameters before and after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr V Rani

Government Siddha medical college, chennai

ranimoorthybsms19@gmail.com9442286863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026